{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:56:38Z","timestamp":1760784998826,"version":"3.40.5"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Xanthine oxidoreductase (XOR) is known as an enzyme related to purine metabolism, catalysing the oxidation of hypoxanthine to xanthine and of xanthine to uric acid. We investigated the relationship between plasma XOR activity in stable kidney transplantation (KT) recipients and carotid artery lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 42 KT patients visiting our outpatient clinic on regular basis were recruited. Associations between plasma XOR activity and the existence of plaque in the common carotid artery (CCA) or internal carotid artery (ICA) and maximum intima\u2010medial thickness (IMT) of CCA (max\u2010CIMT)\u2009&gt;\u20090.9\u2009mm were examined using univariate and multivariate analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At blood sampling, the mean and <jats:italic>SD<\/jats:italic> patient age was 52.7\u2009\u00b1\u200913.8\u2009years old. Plasma XOR(pmol\/h\/ml) activity was significantly higher in patients with CCA\/ICA plaque or max\u2010CIMT &gt;0.9\u2009mm than those without. [23.9 (11.8, 38.3) vs. 8.29 (6.67, 17.5), <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.01, 23.9 (16.9, 71.2) vs. 9.16 (6.67, 28.2), <jats:italic>p<\/jats:italic>\u00a0=\u00a0.01] Univariate and multivariate logistic regression analyses revealed age and plasma XOR activity as independent predictors of CCA\/ICA plaque or max\u2010CIMT &gt;0.9\u2009mm. Receiver operator characteristic curve analyses revealed that the cutoff value of plasma XOR activity for the diagnosis of CCA\/ICA plaque or CCA\u2010IMT\u2009&gt;\u20090.9\u2009mm was 16.3\u00a0pmol\/h\/ml.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma XOR activity is associated independently with atherosclerotic changes in the carotid artery of stable post\u2010KT patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nep.13983","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T11:48:33Z","timestamp":1633780113000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma xanthine oxidoreductase is associated with carotid atherosclerosis in stable kidney transplant recipients"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9713-8625","authenticated-orcid":false,"given":"Rikako","family":"Oki","sequence":"first","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Hamasaki","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Komaru","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-2946","authenticated-orcid":false,"given":"Yoshihisa","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Akari","sequence":"additional","affiliation":[{"name":"Medical Affairs Department Sanwa Kagaku Kenkyusho Co., Ltd.  Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Medical Affairs Department Sanwa Kagaku Kenkyusho Co., Ltd.  Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayo","family":"Murase","sequence":"additional","affiliation":[{"name":"Radioisotope and Chemical Analysis Center Mie Research Park, Sanwa Kagaku Kenkyusho Co., Ltd.  Mie Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-1439","authenticated-orcid":false,"given":"Kent","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Acute Medicine The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Department of Hemodialysis and Apheresis The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_8_2_1","DOI":"10.1056\/NEJMoa041031"},{"doi-asserted-by":"publisher","key":"e_1_2_8_3_1","DOI":"10.1093\/ndt\/gfz053"},{"doi-asserted-by":"publisher","key":"e_1_2_8_4_1","DOI":"10.1159\/000495081"},{"doi-asserted-by":"publisher","key":"e_1_2_8_5_1","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"doi-asserted-by":"publisher","key":"e_1_2_8_6_1","DOI":"10.1253\/circj.CJ-18-0082"},{"doi-asserted-by":"publisher","key":"e_1_2_8_7_1","DOI":"10.1016\/j.atherosclerosis.2014.10.006"},{"key":"e_1_2_8_8_1","first-page":"29","article-title":"Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi\u2010tasking enzyme","volume":"9","author":"Battelli MG","year":"2014","journal-title":"Biochim Biophys Acta"},{"doi-asserted-by":"publisher","key":"e_1_2_8_9_1","DOI":"10.1056\/NEJM199901073400103"},{"doi-asserted-by":"publisher","key":"e_1_2_8_10_1","DOI":"10.1093\/ndt\/14.1.160"},{"doi-asserted-by":"publisher","key":"e_1_2_8_11_1","DOI":"10.1161\/JAHA.117.007720"},{"doi-asserted-by":"publisher","key":"e_1_2_8_12_1","DOI":"10.1093\/eurheartj\/ehw106"},{"doi-asserted-by":"publisher","key":"e_1_2_8_13_1","DOI":"10.1159\/000097034"},{"doi-asserted-by":"publisher","key":"e_1_2_8_14_1","DOI":"10.1016\/j.jchromb.2016.10.033"},{"doi-asserted-by":"publisher","key":"e_1_2_8_15_1","DOI":"10.1161\/01.STR.0000147723.52033.9e"},{"doi-asserted-by":"publisher","key":"e_1_2_8_16_1","DOI":"10.1161\/circ.106.25.3143"},{"doi-asserted-by":"publisher","key":"e_1_2_8_17_1","DOI":"10.1001\/jama.1979.03290450033020"},{"issue":"1","key":"e_1_2_8_18_1","article-title":"The relationship between xanthine oxidoreductase and xanthine oxidase activities in plasma and kidney dysfunction","volume":"2","author":"Terawaki Hiroyuki MT","year":"2017","journal-title":"J Clin Exp Nephrol"},{"doi-asserted-by":"publisher","key":"e_1_2_8_19_1","DOI":"10.1016\/j.ijcard.2016.11.077"},{"doi-asserted-by":"publisher","key":"e_1_2_8_20_1","DOI":"10.1111\/jdi.12870"},{"doi-asserted-by":"publisher","key":"e_1_2_8_21_1","DOI":"10.1093\/ckj\/sfx091"},{"doi-asserted-by":"publisher","key":"e_1_2_8_22_1","DOI":"10.1016\/j.jamcollsurg.2010.06.391"},{"doi-asserted-by":"publisher","key":"e_1_2_8_23_1","DOI":"10.1007\/s11906-010-0103-9"},{"doi-asserted-by":"publisher","key":"e_1_2_8_24_1","DOI":"10.1186\/s12872-018-0757-9"},{"doi-asserted-by":"publisher","key":"e_1_2_8_25_1","DOI":"10.2215\/CJN.01580210"},{"doi-asserted-by":"publisher","key":"e_1_2_8_26_1","DOI":"10.1007\/s10157-012-0742-z"},{"doi-asserted-by":"publisher","key":"e_1_2_8_27_1","DOI":"10.1007\/s00210-016-1239-1"},{"key":"e_1_2_8_28_1","first-page":"7","article-title":"Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats","volume":"478039","author":"Sagor MA","year":"2015","journal-title":"Oxidative Med Cell Longev"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.13983","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/nep.13983","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.13983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:23:12Z","timestamp":1692854592000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nep.13983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/nep.13983"],"URL":"https:\/\/doi.org\/10.1111\/nep.13983","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"type":"print","value":"1320-5358"},{"type":"electronic","value":"1440-1797"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"assertion":[{"value":"2021-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}